Acute Respiratory Distress Syndrome
Cross-source consensus on Acute Respiratory Distress Syndrome from 1 sources and 5 claims.
1 sources · 5 claims
How it works
Benefits
Risks & contraindications
Evidence quality
Highlighted claims
- COVID-19 lung injury triggers a fibrotic phase that stiffens alveoli and parenchyma, substantially increasing the respiratory work required. — COVID-19 ICU Treatment: Clinical Updates and Protocols
- Mechanical ventilation for ARDS produces some permanent reduction in lung function regardless of cause, though the magnitude is highly individual. — COVID-19 ICU Treatment: Clinical Updates and Protocols
- Patients with pre-existing lung conditions such as COPD or pulmonary fibrosis may be permanently pushed past the threshold for ventilator dependence by COVID-19 ARDS. — COVID-19 ICU Treatment: Clinical Updates and Protocols
- Historical data from ARDS of non-COVID etiologies shows modest but measurable decreases in forced vital capacity persisting after ICU discharge. — COVID-19 ICU Treatment: Clinical Updates and Protocols
- Approximately 80% of COVID-19 infections do not require hospitalization; of those hospitalized, roughly 50–70% are being discharged. — COVID-19 ICU Treatment: Clinical Updates and Protocols